Pilot Study to Determine the Feasibility of Fluconazole for Induction Treatment and Suppression of Relapse of Histoplasmosis in Patients With the Acquired Immunodeficiency Syndrome
This study has been completed.
Study NCT00000627
Information provided by National Institute of Allergy and Infectious Diseases (NIAID)
First Received on November 2, 1999.
Last Updated on March 30, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
